Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential

Journal of Biological Chemistry

Volumn 278, Issue 18, 2003, Pages 15958-15965

  Lin, Ding Yen ^a   Lai, Ming Zong ^b   Ann, David K ^c   Shih, Hsiu Ming ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CHEMICAL ACTIVATION; FLUORESCENCE; GENES; IMMUNOLOGY; TUMORS; VIRUSES;

TRANSCRIPTIONAL ACTIVATION;

PROTEINS;

CELL PROTEIN; DAXX PROTEIN; GLUCOCORTICOID RECEPTOR; PROMYELOCYTIC LEUKEMIA PROTEIN; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ARSENIC TRIOXIDE; CARRIER PROTEIN; DAXX PROTEIN, HUMAN; DAXX PROTEIN, MOUSE; NUCLEAR PROTEIN; ORGANOARSENIC DERIVATIVE; OXIDE; PML PROTEIN, HUMAN; PML PROTEIN, MOUSE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CELL STRAIN COS1; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; ANIMAL; CHEMISTRY; GENETICS; MOUSE MAMMARY TUMOR ONCOVIRUS; PHYSIOLOGY;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ARSENICALS; CARRIER PROTEINS; COS CELLS; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMARY TUMOR VIRUS, MOUSE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OXIDES; PROMOTER REGIONS (GENETICS); RECEPTORS, GLUCOCORTICOID; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0037507271     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M300387200     Document Type: Article

References (37)

1. Barnes, P. J. (1998) Clin. Sci. (Lond) 94, 557-572
2. Sapolsky, R. M., Romero, L. M., and Munck, A. U. (2000) Endocr. Rev. 21, 55-89
3. Adcock, I. M. (2001) Pulm. Pharmacol. Ther. 14, 211-219
4. Almawi, W. Y., and Melemedjian, O. K. (2002) J. Leukoc. Biol. 71, 9-15
5. Distelhorst, C. W. (2002) Cell Death Differ. 9, 6-19
6. Olefsky, J. M. (2001) J. Biol. Chem. 276, 36863-36864
7. Beato, M., and Sanchez-Pacheco, A. (1996) Endocr. Rev. 17, 587-609
8. Robyr, D., Wolffe, A. P., and Wahli, W. (2000) Mol. Endocrinol 14, 329-347
9. Rosenfeld, M. G., and Glass, C. K. (2001) J. Biol. Chem. 276, 36865-36868
10. Collingwood, T. N., Urnov, F. D., and Wolffe, A. P. (1999) J. Mol. Endocrinol. 23, 255-275
11. Doucas, V., Tini, M., Egan, D. A., and Evans, R. M. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2627-2632
12. Hatta, M., and Fukamizu, A. (2001) Science's STKE, http://stke.sciencemag.org/cgi/content/full/sigtrans;2001/112/e1
13. Borden, K. L. (2002) Mol. Cell. Biol. 22, 5259-5269
14. Yu, C., Yap, N., Chen, D., and Cheng, S. (1997) Cancer Lett. 116, 191-196
15. Sengupta, S., Vonesch, J. L., Waltzinger, C., Zheng, H., and Wasylyk, B. (2000) EMBO J. 19, 6051-6064
16. Singh, P., Chan, S. W., and Hong, W. (2001) J. Biol. Chem. 276, 13762-13770
17. Le Drean, Y., Mincheneau, N., Le Goff, P., and Michel, D. (2002) Endocrinology 143, 3482-3489
18. Tian, S., Poukka, H., Palvimo, J. J., and Janne, O. A. (2002) Biochem. J. 367, 907-911
19. Torii, S., Egan, D. A., Evans, R. A., and Reed, J. C. (1999) EMBO J. 18, 6037-6049
20. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. F., III, and Maul, G. G. (1999) J. Cell Biol. 147, 221-234
21. Li, H., Leo, C., Zhu, J., Wu, X., O'Neil, J., Park, E. J., and Chen, J. D. (2000) Mol. Cell. Biol. 20, 1784-1796
22. Hollenbach, A. D., Sublett, J. E., McPherson, C. J., and Grosveld, G. (1999) EMBO J. 18, 3702-3711
23. Li, R., Pei, H., Watson, D. K., and Papas, T. S. (2000) Oncogene 19, 745-753
24. Emelyanov, A. V., Kovac, C. R., Sepulveda, M. A., and Birshtein, B. K. (2002) J. Biol. Chem. 277, 11156-11164
25. Lin, D. Y., and Shih, H. M. (2002) J. Biol. Chem. 277, 25446-25456
26. Lehembre, F., Muller, S., Pandolfi, P. P., and Dejean, A. (2001) Oncogene 20, 1-9
27. Yang, X., Khosravi-Far, R., Chang, H. Y., and Baltimore, D. (1997) Cell 89, 1067-1076
28. Charette, S. J., and Landry, J. (2000) Ann. N. Y. Acad. Sci. 926, 126-131
29. Michaelson, J. S., Bader, D., Kuo, F., Kozak, C., and Leder, P. (1999) Genes Dev. 13, 1918-1923
30. Pluta, A. F., Earnshaw, W. C., and Goldberg, I. G. (1998) J. Cell Sci. 111, 2029-2041
31. Lalioti, V. S., Vergarajauregui, S., Pulido, D., and Sandoval, I. V. (2002) J. Biol. Chem. 277, 19783-19791
32. Ryu, S. W., Chae, S. K., and Kim, E. (2000) Biochem. Biophys. Res. Commun. 279, 6-10
33. Hollenbach, A. D., McPherson, C. J., Mientjes, E. J., Iyengar, R., and Grosveld, G. (2002) J. Cell Sci. 115, 3319-3330
34. Lin, R. J., Sternsdorf, T., Tini, M., and Evans, R. M. (2001) Oncogene 20, 7204-7215
35. Guiochon-Mantel, A., Savouret, J. F., Quignon, F., Delabre, K., Milgrom, E., and De The, H. (1995) Mol. Endocrinol 9, 1791-1803
36. Vallian, S., Gaken, J. A., Gingold, E. B., Kouzarides, T., Chang, K. S., and Farzaneh, F. (1998) Oncogene 16, 2843-2853
37. Zhong, S., Delva, L., Rachez, C., Cenciarelli, C., Gandini, D., Zhang, H., Kalantry, S., Freedman, L. P., and Pandolfi, P. P. (1999) Nat. Genet. 23, 287-295